Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
19 August 2022 - 4:00PM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to view and listen to a webcast of a discussion with Mikael
Dolsten, Chief Scientific Officer, President, Worldwide Research,
Development and Medical, at the Handelsbanken Life Science
Innovation Day 2022 on Wednesday, August 24, 2022 at 4:30 p.m. CEST
(10:30 a.m. EDT).
To view and listen to the webcast, visit our web site at
www.pfizer.com/investors. Information on accessing and registering
for the webcast will be available at www.pfizer.com/investors
beginning today.
The transcript and webcast replay of the discussion will be made
available on our web site at www.pfizer.com/investors within 24
hours after the end of the live discussion and will be accessible
for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 170 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, expectations
for our product pipeline, in-line products and product candidates,
including anticipated regulatory submissions, data read-outs, study
starts, approvals, clinical trial results and other developing
data, revenue contribution, growth, performance, timing of
exclusivity and potential benefits, our anticipated operating and
financial performance, reorganizations, business plans, strategy
and prospects; strategic reviews; capital allocation objectives;
plans for and prospects of our acquisitions, dispositions and other
business development activities, and our ability to successfully
capitalize on these opportunities; manufacturing and product
supply; and our efforts to respond to COVID-19, including the
Pfizer-BioNTech COVID-19 vaccine (Comirnaty) and our oral COVID-19
treatment (Paxlovid), that are subject to substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. A description
of these risks and uncertainties can be found in Pfizer’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2021 and
in its subsequent reports on Form 10-Q, including in the sections
thereof captioned “Risk Factors” and “Forward-Looking Information
and Factors That May Affect Future Results”, as well as in its
subsequent reports on Form 8-K, all of which are filed with the
U.S. Securities and Exchange Commission and available at
www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
Category: Finance
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220819005016/en/
Media Contact: PfizerMediaRelations@Pfizer.com +1 (212)
733-1226
Investor Contact: IR@Pfizer.com +1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
Von Apr 2023 bis Apr 2024